mlitan

Cancer treatment medications will be available in Libya starting in April, says the head of the Support and Development Agency for Therapeutic Services in Libya, Ahmed Melitan.

The Government of National Unity's public tender to various pharmaceutical companies will facilitate the provision of these treatments, which have been in short supply within the country, the agency stated, citing its head.

Melitan highlighted the pressing need of cancer patients for such medications, noting the exorbitant prices in the local market compared to the average citizen's income.

He emphasized efforts to localize radiation therapy by opening a specialized centre at the Tripoli Central Hospital, which was inaugurated last December. 

The Centre, under the supervision of the National Authority for Cancer Control and in collaboration with the Support and Development Agency for Therapeutic Services, conducts 120 radiation therapy sessions per day.